Arvin Yang
2023
In 2023, Arvin Yang earned a total compensation of $1.9M as Former Senior Vice President, Chief Medical Officer at Mersana Therapeutics, a 24% increase compared to previous year.
Compensation breakdown
| Option Awards | $1,053,396 |
|---|---|
| Salary | $409,744 |
| Stock Awards | $292,898 |
| Other | $156,314 |
| Total | $1,912,352 |
Yang received $1.1M in option awards, accounting for 55% of the total pay in 2023.
Yang also received $409.7K in salary, $292.9K in stock awards and $156.3K in other compensation.
Rankings
In 2023, Arvin Yang's compensation ranked 553rd out of 2,878 executives tracked by ExecPay. In other words, Yang earned more than 80.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 553 out of 2,878 | 81st |
Division Manufacturing | 317 out of 1,582 | 80th |
Major group Chemicals And Allied Products | 221 out of 891 | 75th |
Industry group Drugs | 218 out of 854 | 75th |
Industry Pharmaceutical Preparations | 136 out of 614 | 78th |
Source: SEC filing on April 26, 2024.
Yang's colleagues
We found six more compensation records of executives who worked with Arvin Yang at Mersana Therapeutics in 2023.
2023
Anna Protopapas
Mersana Therapeutics
Chief Executive Officer
2023
Martin Huber
Mersana Therapeutics
Chief Executive Officer
2023
Brian DeSchuytner
Mersana Therapeutics
Chief Financial Officer
2023
Timothy Lowinger
Mersana Therapeutics
Senior Vice President, Chief Science and Technology Officer
2023
Alejandra Carvajal
Mersana Therapeutics
Chief Legal Officer
2023
Mohan Bala
Mersana Therapeutics
Senior Vice President, Chief Development Officer
News
Mersana Therapeutics CEO Anna Protopapas' 2023 pay jumps 56% to $4.5M
April 26, 2024
Mersana Therapeutics CEO Anna Protopapas' 2022 pay falls 66% to $2.8M
April 28, 2023
Mersana Therapeutics CEO Anna Protopapas' 2021 pay jumps 226% to $8.3M
April 29, 2022
Mersana Therapeutics Chief Medical Officer Arvin Yang receives $4.5M in 2020
April 27, 2021